With healthcare at a key crossroads of policy, technology, and science, Sanofi CEO Paul Hudson shares the Big Pharma’s ...

GSK announced plans to invest $30bn across the US in research and development and supply chain infrastructure over the next five years. This includes a new $1.2bn investment in advanced manufacturing ...

A long-coveted deal to slash US steel and aluminium tariffs to zero has been shelved on the eve of Donald Trump’s state visit ...

Paul Hudson has a blunt view of peers who hand off the execution of their artificial intelligence strategy to their chief ...